Steering Committee

The Steering Committee (SC) is a scientific and innovation-focused committee to ensure the strategic coordination and main decision-making of Inno4Vac. It is composed of 14 members representatives of the following:  

 

Composition

  • Project coordinator: Ole Olesen, European Vaccine Initiative (EVI) 

  • Industry Leader: Sandra Morel, GlaxoSmithKline (GSK)

  • Scientific coordinator: Donata Medaglini, Sclavo Vaccine Association (SVA) 

  • Industry Co-Leader: Lucile Plourde, Sanofi Pasteur (SP) 

  • EFPIA partners: Karl Melber, CureVac (CureVac) and Elke Walter, Takeda (Takeda)

Subtopics Academic Leaders & Industry Co-leaders

ST1

Academic Lead: Gunnveig Grodeland, University of Oslo (UiO)

Industry Co-Lead: Guglielmo Roma, GlaxoSmithKline (GSK)

ST2

Academic Lead: Meta Roestenberg, Leiden University Medical Center (LUMC)

Industry Co-Lead: Jeanne-Marie Devaster, GlaxoSmithKline (GSK)

ST3

Academic Lead: Cecile van Els, Rijksinstituut voor Volksgezondheid en Milieu (RIVM)

Industry Co-Lead: Fabienne Piras-Douce, Sanofi Pasteur (SP) 

ST4

Academic Lead: Daniel Bracewell, University College London (UCL)

Industry Co-Lead: Eric Calvosa, Sanofi Pasteur (SP)